Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone

@article{Korhonen2008IdentificationOT,
  title={Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone},
  author={T. Korhonen and M. Turpeinen and A. Tolonen and K. Laine and O. Pelkonen},
  journal={The Journal of Steroid Biochemistry and Molecular Biology},
  year={2008},
  volume={110},
  pages={56-66}
}
  • T. Korhonen, M. Turpeinen, +2 authors O. Pelkonen
  • Published 2008
  • Chemistry, Medicine
  • The Journal of Steroid Biochemistry and Molecular Biology
    • This study examined the cytochrome P450 (CYP) enzyme selectivity of in vitro bioactivation of lynestrenol to norethindrone and the further metabolism of norethindrone. Screening with well-established chemical inhibitors showed that the formation of norethindrone was potently inhibited by CYP3A4 inhibitor ketoconazole (IC(50)=0.02 microM) and with CYP2C9 inhibitor sulphaphenazole (IC(50)=2.13 microM); the further biotransformation of norethindrone was strongly inhibited by ketoconazole (IC(50)=0… CONTINUE READING
    View on Elsevier
    doi.org
    32 Citations
    Highly Influencial Citations
    1
    Background Citations
    8
    32 Citations
    Citation Type

    Citation Type

    A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies.
    • 70
    Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications
    • Y. Zhang, L. Yang
    • Biology, Medicine
    • Expert opinion on drug metabolism & toxicology
    • 2009
    • 23
    Selective whole-cell biosynthesis of the designer drug metabolites 15- or 16-betahydroxynorethisterone by engineered Cytochrome P450 BM3 mutants
    • 9
    Chapter 6 Selective whole-cell biosynthesis of the designer drug metabolites 15-or 16-β-hydroxynorethisterone by engineered cytochrome P 450 BM 3 mutants
    • 2015
    • PDF
    Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein
    • 29
    Prediction of regioselectivity and preferred order of metabolisms on CYP1A2-mediated reactions. Part 2: Solving substrate interactions of CYP1A2 with non-PAH substrates on the template system.
    • 8
    Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR.
    • 42
    Involvement of cytochrome P450 enzymes in inflammation and cancer: a review
    • 1
    Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
    • 54
    • PDF
    The Influence of in Vitro Gill and Liver Metabolism of Xenobiotics on Fish Bioconcentration
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 48 REFERENCES
    In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    • 70
    Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    • 103
    • PDF
    Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.
    • 197
    A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes.
    • 50
    Role of CYP2C9 polymorphism in losartan oxidation.
    • 153
    • PDF
    Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    • 157
    Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    • 108
    Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.
    • 118
    In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
    • 108
    Cytochrome P450 (CYP) inhibition screening: comparison of three tests.
    • M. Turpeinen, L. E. Korhonen, +4 authors O. Pelkonen
    • Chemistry, Medicine
    • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
    • 2006
    • 59